OncoHost Wins 2023 BIG Innovation Award for PROphet® Platform

Original source here.

OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced that its PROphet® platform has been named a winner in the healthcare category of the 2023 BIG Innovation Awards presented by the Business Intelligence Group (BIG). "Innovation is 'business critical' in today's society," said Maria Jimenez, Chief Operating Officer of the Business Intelligence Group. "We are thrilled to be honoring OncoHost as they are leading by example and improving the lives of so many." PROphet® is a first-of-its-kind platform that employs high-throughput proteomic profiling technology to assess patient response to treatment, enabling oncologists to provide truly personalized care. Analyzing just one pre-treatment blood sample, PROphet® scans proteins in a patient's plasma to identify patterns that decode the cancer resistance mechanisms in their body. These patterns are predictive of the patient's likeliness to obtain clinical benefit from their treatment.